January 07, 2022
1 min read
Save
iPRIME viscodelivery system receives FDA 510(k) clearance
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The FDA has granted 510(k) clearance to the iPRIME viscodelivery system, according to a press release from Glaukos.
iPRIME is a single-use, sterile, minimally invasive device used to deliver viscoelastic fluid during ophthalmic surgery.
“We are thrilled to announce this clearance as we believe iPRIME will be another important tool that supports the needs of physicians and patients,” Thomas Burns, Glaukos president and CEO, said in the release. “This technology further expands Glaukos’ broad portfolio of innovative ophthalmic solutions and is consistent with our long-standing position on the value of truly minimally invasive therapy.”
Published by:
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.